Change search criteria ↓

Search results

18 projects found matching your search criteria:

  1. 1. Molecular insights into NAD+ metabolism in Huntington's disease: role in pathophysiology and preclinical assessment of t…

    Principal investigator: dr hab. Marta Urszula Tomczyk

    Gdański Uniwersytet Medyczny

    Call: OPUS 28, Panel: NZ5

  2. 2. Identification of novel disease modifiers in Huntington's disease: neuro-glia interactions in the patient-derived multid…

    Principal investigator: dr Agnieszka Marta Krzyżosiak

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

    Call: SONATA BIS 11, Panel: NZ3

  3. 3. Molecular mechanisms of genistein-mediated autophagy stimulation, and its cellular and physiological effects in Huntingt…

    Principal investigator: prof. Grzegorz Władysław Węgrzyn

    Uniwersytet Gdański, Wydział Biologii

    Call: OPUS 19, Panel: NZ2

  4. 4. Linking abnormal Ca2+ signaling and the unfolded protein response with Huntington's disease pathology in both YAC128 mou…

    Principal investigator: dr Magdalena Czeredys

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

    Call: OPUS 17, Panel: NZ3

  5. 5. Discovering disorders of brain development in Huntington disease as a consequence of putative total huntingtin deficienc…

    Principal investigator: dr hab. Maciej Figiel

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 16, Panel: NZ3

  6. 6. Role of arginase 2 in the function of the striatum and in the pathogenesis of Huntington's disease

    Principal investigator: dr Michał Tadeusz Węgrzynowicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: SONATA BIS 8, Panel: NZ1

  7. 7. Modulation of mutant huntingtin level by genistein in the mouse model of Huntington's disease and its effects on psychom…

    Principal investigator: Karolina Pierzynowska

    Uniwersytet Gdański, Wydział Biologii

    Call: PRELUDIUM 13, Panel: NZ2

  8. 8. Changes in human skin cells mitochondria carrying mutations causing Huntington's diseasae

    Principal investigator: Paulina Jędrak

    Uniwersytet Gdański, Wydział Biologii

    Call: PRELUDIUM 9, Panel: NZ2

  9. 9. MicroRNA profiling in cellular models of Huntington's disease generated using iPSC technology

    Principal investigator: dr Emilia Barbara Kozłowska

    Instytut Chemii Bioorganicznej PAN

    Call: PRELUDIUM 9, Panel: NZ2

  10. 10. Role of CacyBP/SIP in the dysregulation of beta-catenin ubiquitination in YAC128 mouse model of Huntington's disease

    Principal investigator: dr Magdalena Czeredys

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

    Call: SONATA 8, Panel: NZ3

  11. 11. The role of mitochondrial DNA and epigenetic factors in the pathogenesis of Huntington's disease

    Principal investigator: prof. Janusz Limon

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 2, Panel: NZ2

  12. 12. VDAC channel as a target of huntingtin in the etiology of Huntington's disease

    Principal investigator: prof. Hanna Małgorzata Kmita

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: OPUS 1, Panel: NZ3

  13. 13. The use of artificial miRNAs in the therapy of Huntington's Disease

    Principal investigator: dr Anna Kotowska-Zimmer

    Instytut Chemii Bioorganicznej PAN

    Call: PRELUDIUM 20, Panel: NZ1

  14. 14. Defining (sex and age) cell-specific epigenetic mechanisms underlying EnvironmentalEnrichment/Exercise as non-pharmacolo…

    Principal investigator: dr hab. Bartosz Zbigniew Wilczyński

    Uniwersytet Warszawski

    Call: JPND Call 2022, Panel: NZ2

  15. 15. Comprehensive analysis of the therapeutic potential of oligonucleotides for the treatment of polyglutamine diseases

    Principal investigator: dr hab. Agnieszka Fiszer

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 9, Panel: NZ5

  16. 16. Searching for new therapeutic targets in polyglutamine diseases

    Principal investigator: prof. Marta Olejniczak

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 22, Panel: NZ2

  17. 17. Human iPSC-derived cortico-striatal assembloids as a new model to studyneurodevelopmental pathologies induced by mutant …

    Principal investigator: dr Magdalena Czeredys

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 25, Panel: NZ3

  18. 18. Investigation of DNA double-strand break repair mechanisms in microsatellite regions using the CRISPR/Cas system

    Principal investigator: dr hab. Marta Olejniczak

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 15, Panel: NZ1

Graphic design and implementation: Jakub Piotrowski